Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
about
Role of ENPP1 on adipocyte maturationStructure and function of human xylulokinase, an enzyme with important roles in carbohydrate metabolismMalonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscleThe AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivityNon-alcoholic fatty liver disease: what the clinician needs to know.Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese menCentral role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndromeIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewTranscriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell functionAssociation of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS studyPrevalence, predisposition and prevention of type II diabetes.Type-2 diabetes: Current understanding and future perspectivesOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusInterplay between lipids and branched-chain amino acids in development of insulin resistanceType 2 diabetes: etiology and reversibilityWinning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology.Endothelial Cell Surface Expressed Chemotaxis and Apoptosis Regulator (ECSCR) Regulates Lipolysis in White Adipocytes via the PTEN/AKT Signaling PathwayDefect of insulin signal in peripheral tissues: Important role of ceramideThe action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1Performance Enhancing Diets and the PRISE Protocol to Optimize Athletic PerformanceReduced PDK4 expression associates with increased insulin sensitivity in postobese patientsA branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistancePlasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American womenInsulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathwayGlucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout miceChronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin ResistanceRetinoids induced Pck1 expression and attenuated insulin-mediated suppression of its expression via activation of retinoic acid receptor in primary rat hepatocytesTesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker ratsObesogenic high fat western diet induces oxidative stress and apoptosis in rat heartDistinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulinNovel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cellsThe extreme C terminus of rat liver carnitine palmitoyltransferase I is not involved in malonyl-CoA sensitivity but in initial protein foldingWnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblastsRegulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort studyInsulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes?A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortiumExercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance.Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?
P2860
Q24293330-2D88252A-0A62-4E51-B1CB-3BF9A34B4576Q24304925-6B02198A-0B03-4615-B898-5E2CA2404C65Q24554303-74773077-0856-4222-BF28-4F3799650EEDQ24554361-CBEC3719-6C34-4B06-BA81-36EC29648010Q24563068-AB4B420C-DB8E-402B-826B-BC06C6ABA312Q24617779-D7B341F2-001A-4A5C-BD39-B4177FF967C1Q24648112-1202AE92-8B2B-40D2-9B84-243CB7EA6609Q24796491-D73A9078-16E8-46A7-988C-EB0FCEFB571FQ24801508-5B2F55B4-08AD-4FC6-8065-DD9DBCEF93C1Q24803245-C9E95AE8-DE9C-4D75-A848-CB59B8444C1EQ24813954-D8E54749-A8BF-4F41-B64B-0BE9844331B7Q24815863-C722DAA1-0720-48D8-8587-07AE9C54BA3EQ26801324-BF9C1D3A-6D14-4A7F-A663-0F21F11CB4F3Q26829529-7FDBB78D-7957-412C-8A3F-AF8F8EFD6EE8Q26852310-78DE7FD5-D6C2-4469-AFF4-842E81201F4BQ27016644-E5B4B6D6-2A73-4B73-B32E-59950338A2DAQ27320960-E47108C9-F614-4BE3-A057-2EB8B9439B9BQ27336071-DF939AA2-6C6A-4BF2-966F-62F0419B58B7Q27690875-A2B3EEFC-4D1D-4CCE-B326-0ACB6866FBE2Q27865233-292CBF66-D2CB-48D8-A8EB-5ECB14B94D09Q28080853-90F2C2B3-A927-4ADB-8398-B0AEE0C837B2Q28208886-3A4253D8-F9CB-4410-9052-54C1E44E2811Q28240815-97D1BD86-A96B-4975-8035-58FAAF8486C2Q28476486-DB8262AA-A9E5-4D80-8226-D841FE4C9F86Q28505405-3088B128-B442-4311-9285-647FFC0DB1D9Q28506934-3AEBA6D6-D223-4D61-89D1-8B322BC07ABAQ28555023-2AEB6C7D-8B39-419E-BF59-05C7203C8B8BQ28566684-D160F2B7-2315-42DB-9863-ED3F9ADBDFECQ28572510-1DE90839-3242-47CA-80C4-28AF7B1383E5Q28573796-B0C4D1EB-3B1A-4832-9019-747320971CE9Q28574224-C3834222-4A99-440F-8089-7C18F1B3BC31Q28574936-F465E794-AF6A-49FF-A71C-50409F024334Q28577659-C75C143E-1A56-4EE5-B019-518C139481D1Q28588627-5545DD87-6482-47B7-BBBB-D8E10067061BQ28592284-E408C184-E979-47F1-8157-6B914C7E8A0EQ28728319-AA8573CB-A72F-47FC-A1FF-B8AEFAD08455Q28766365-9AC9DE54-5C36-413D-B0D9-3DC7A64F91E1Q28943346-F9E33DB9-7370-4CBA-9575-89523DA1B61FQ30276917-131A42B5-FB22-4B00-B97C-B2004EA7BF72Q30352122-21B3DB19-2A68-4EE7-A51D-A38A6609CCF0
P2860
Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@en
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@nl
type
label
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@en
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@nl
prefLabel
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@en
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@nl
P356
P1433
P1476
Banting lecture 2001: dysregul ...... e etiology of type 2 diabetes.
@en
P2093
J Denis McGarry
P356
10.2337/DIABETES.51.1.7
P407
P577
2002-01-01T00:00:00Z